Curio Biotech

Curio Biotech is a specialized, human-biology-focused Contract Research Organization (CRO) based in Visp, Switzerland. It offers a suite of in vitro testing services using primary human cells and sophisticated 3D models to generate translational data for clients in pharmaceuticals, cosmetics, and biotechnology, with applications across dermatology, aging, immuno-oncology, and metabolic diseases. The company positions itself at the intersection of the growing demand for predictive human models and the global regulatory push to reduce animal testing. As a private service provider, its financial model is based on fee-for-service contracts, catering to an innovation-driven market from its location in the Swiss BioArk biotech park.

Integrated platform utilizing primary human cell cultures, advanced 3D tissue-engineered models, and ex vivo systems to create predictive, human-relevant, animal-free in vitro assays for drug discovery and safety testing.

Operates in the competitive preclinical CRO sector, competing against large, diversified players (e.g., Charles River, LabCorp) and other specialized human biology-focused boutiques. Differentiation is based on deep expertise in primary human cell systems and 3D models, and alignment with the animal-free testing movement.